Anyone who has run, grown and/or sold a business, worked on wall street or in finance....is on the angry side.
Exactly.
The unique issue with this company is that it isn't a scam or a bad product. And that's what makes people so mad. If it were a scam or a bad product, I wouldn't care because I wouldn't want to invest at all.
It's a great product, with loads of potential, that will likely be successful and as such, you should WANT to invest.
The problem is, management is so bad, that investing right now isn't a great idea because if you know anything about finance you can see that this company has put themselves in a very difficult position to pay back their current investors. Even if I knew for 100% certainty that manufacturing would be in place to fill global demand by EOY 2023 and all 4 RA's would be approving in 2023, I still would be hesitant to invest right now because the company doesn't have the financial means to make it to that point.
The risk is huge; not because of the science, or the approvals, or big pharma thugs. But because the company has so poorly managed PR/IR that the share price has become restrictive to capital raises, dilution is necessary, and there is no value to limit the damage to existing shareholders that dilution will do. So why invest now, when I can wait and capitalize on NWBO's incompetence and get a much better position in 4 months after they have completely blown up the existing share structure?
Market Data 
Markets 
AI
